This inventor holds 1 USPTO granted patent. Top assignee: Sumitomo Pharma Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Hiroaki Tanaka: Innovator in Medicinal Chemistry
Introduction
Hiroaki Tanaka is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds for treating nervous system and psychiatric diseases. His innovative work has led to the filing of a patent that showcases his expertise and dedication to improving healthcare.
Latest Patents
Hiroaki Tanaka holds a patent for a benzisoxazole derivative. This invention relates to a medicament designed for treating various nervous system diseases or psychiatric diseases. The patent includes a compound of formula (1) or a pharmaceutically acceptable salt thereof as an active ingredient, where Ris hydrogen, etc., Ris halogen, etc., and R, R, R, and R are hydrogen, etc. This innovative approach highlights his commitment to addressing complex medical challenges.
Career Highlights
Hiroaki Tanaka is associated with Sumitomo Pharma Co., Ltd., a leading pharmaceutical company in Japan. His role at the company allows him to collaborate with other talented professionals in the field. His work has not only contributed to the company's portfolio but has also advanced the understanding of treatments for psychiatric and nervous system disorders.
Collaborations
Hiroaki Tanaka has worked alongside notable colleagues such as Tomoyuki Tanaka and Yoshiaki Isobe. These collaborations have fostered a productive environment for innovation and research, leading to advancements in medicinal chemistry.
Conclusion
Hiroaki Tanaka's contributions to the field of medicinal chemistry are noteworthy. His patent for a benzisoxazole derivative exemplifies his innovative spirit and dedication to improving healthcare solutions. His work continues to inspire future advancements in the treatment of nervous system and psychiatric diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile